Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 84, 2024 - Issue 1
Submit an article Journal homepage
62
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

IgE-kappa multiple myeloma with kappa free light chain: a case report

Yuyi Hua Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaView further author information
,
Wenqi Shaoa Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaView further author information
,
Baishen Pana Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaView further author information
,
Beili Wanga Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaView further author information
&
Wei Guoa Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China;b Department of Laboratory Medicine, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China;c Department of Laboratory Medicine, Wusong Branch, Zhongshan Hospital, Fudan University, Shanghai, China;d Department of Laboratory Medicine, Shanghai Geriatric Medical Center, Shanghai, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9924-638XView further author information
ORCID Icon
Pages 71-75 | Received 16 Jul 2023, Accepted 21 Jan 2024, Published online: 08 Feb 2024

References

  • Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046–1060. doi: 10.1056/NEJMra1011442.
  • Wang S, Xu L, Feng J, et al. Prevalence and incidence of multiple myeloma in urban area in China: a national population-based analysis. Front Oncol. 2019;9:1513. doi: 10.3389/fonc.2019.01513.
  • Liu W, Liu J, Song Y, et al. Mortality of lymphoma and myeloma in China, 2004–2017: an observational study. J Hematol Oncol. 2019;12(1):22. doi: 10.1186/s13045-019-0706-9.
  • Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–e548. doi: 10.1016/S1470-2045(14)70442-5.
  • Morris C, Drake M, Apperley J, et al. Efficacy and outcome of autologous transplantation in rare myelomas. Haematologica. 2010;95(12):2126–2133. doi: 10.3324/haematol.2010.022848.
  • Johansson SG, Bennich H. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology. 1967;13(4):381–394.
  • Hejl C, Mestiri R, Carmoi T, et al. IgE monoclonal gammopathy: a case report and literature review. Clin Biochem. 2018;51:103–109. doi: 10.1016/j.clinbiochem.2017.09.015.
  • Galakhoff N, Leven C, Eveillard JR, et al. A case of IgE myeloma transformed into IgE-producing plasma cell leukaemia. Biochem Med. 2020;30(1):010801.
  • Chae H, Kim H, Choi A, et al. A rare case of the IgE prozone phenomenon in IgE multiple myeloma. Clin Biochem. 2022;104:59–61. doi: 10.1016/j.clinbiochem.2022.02.001.
  • Chen Y, Chen Y, Zhou Y, et al. Defects and countermeasures in laboratory diagnosis of rare IgE multiple myeloma. Clin Chim Acta. 2022;532:37–44. doi: 10.1016/j.cca.2022.05.011.
  • Nafría Jiménez B, Oliveros Conejero R. IgE multiple myeloma: detection and follow-up. Adv Lab Med. 2022;3(1):79–90. doi: 10.1515/almed-2021-0087.
  • Kehl N, Kilian M, Michel J, et al. IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells. J Immunother Cancer. 2022;10(10):e005815. doi: 10.1136/jitc-2022-005815.
  • Brivio R, Cappellani A, Carpenedo M, et al. IgE monoclonal gammopathy: the clinical relevance to perform the immunofixation using IgE antisera. Int J Lab Hematol. 2020;42(5):e237–e239.
  • Wu XB, Zhou Y, Bao F, et al. [IgE multiple myeloma, one case report]. Zhonghua Nei Ke Za Zhi. 2020;59(11):902–905.
  • Talamo G, Castellani W, Dolloff NG. Prozone effect of serum IgE levels in a case of plasma cell leukemia. J Hematol Oncol. 2010;3(1):32. doi: 10.1186/1756-8722-3-32.
  • Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95(5):548–567. doi: 10.1002/ajh.25791.
  • Larsen JT, Kumar SK, Dispenzieri A, et al. Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma. Leukemia. 2013;27(4):941–946. doi: 10.1038/leu.2012.296.
  • Heaney JLJ, Ackermann F, Paunet-Bobo M, et al. Evaluation of two serum free light chain quantitation methods, freelite and seralite, in the clinical laboratory with a view to switching immunoassay. Clin Chim Acta. 2020;510:235–241. doi: 10.1016/j.cca.2020.07.034.
  • Lock RJ, Saleem R, Roberts EG, et al. A multicentre study comparing two methods for serum free light chain analysis. Ann Clin Biochem. 2013;50(Pt 3):255–261. doi: 10.1177/0004563212473447.
  • Tate JR, Graziani MS, Mollee P, et al. Protein electrophoresis and serum free light chains in the diagnosis and monitoring of plasma cell disorders: laboratory testing and current controversies. Clin Chem Lab Med. 2016;54(6):899–905. doi: 10.1515/cclm-2016-0268.
  • Lu J, Lu J, Chen W, et al. Clinical features and treatment outcome in newly diagnosed Chinese patients with multiple myeloma: results of a multicenter analysis. Blood Cancer J. 2014;4(8):e239–e239. doi: 10.1038/bcj.2014.55.
  • Kumar SK, Callander NS, Adekola K, et al. Multiple myeloma, version 3.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(12):1685–1717. doi: 10.6004/jnccn.2020.0057.
  • Gamundí Grimalt E, Morandeira Rego F, Clapés Puig V, et al. IgE multiple myeloma: a new case report. Clin Chem Lab Med. 2017;55(2):e37–e40. doi: 10.1515/cclm-2016-0354.
  • Jurczyszyn A, Castillo JJ, Vesole DH, et al. Clinical characteristics and treatment outcomes in IgE multiple myeloma: a case-control study. Am J Hematol. 2018;93(9):E238–E241.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.